Schrag SJ - Search Results

1

Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial.

Cutland CL, Madhi SA, Zell ER, Kuwanda L, Laque M, Groome M, Gorwitz R, Thigpen MC, Patel R, Velaphi SC, Adrian P, Klugman K, Schuchat A, Schrag SJ; PoPS Trial Team. Cutland CL, et al. Among authors: schrag sj. Lancet. 2009 Dec 5;374(9705):1909-16. doi: 10.1016/S0140-6736(09)61339-8. Epub 2009 Oct 19. Lancet. 2009. PMID: 19846212 Clinical Trial.

2

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. Schrag SJ, et al. N Engl J Med. 2000 Jan 6;342(1):15-20. doi: 10.1056/NEJM200001063420103. N Engl J Med. 2000. PMID: 10620644 Free article.

3

Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts.

Schrag SJ, Whitney CG, Schuchat A. Schrag SJ, et al. Infect Control Hosp Epidemiol. 2000 Jul;21(7):473-83. doi: 10.1086/501791. Infect Control Hosp Epidemiol. 2000. PMID: 10926399 Review.

4

Early opportunities for prevention: infections of pregnant women and young infants.

Schuchat A, Hillier S, Edwards K, Schrag S, Labbok M. Schuchat A, et al. Emerg Infect Dis. 2001;7(3 Suppl):532. doi: 10.3201/eid0707.017711. Emerg Infect Dis. 2001. PMID: 11485649 Free PMC article. No abstract available.

5

Sentinel surveillance: a reliable way to track antibiotic resistance in communities?

Schrag SJ, Zell ER, Schuchat A, Whitney CG. Schrag SJ, et al. Emerg Infect Dis. 2002 May;8(5):496-502. doi: 10.3201/eid0805.010268. Emerg Infect Dis. 2002. PMID: 11996685 Free PMC article.

6

A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.

Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, Harrison LH, Reingold A, Stefonek K, Smith G, Gamble M, Schuchat A; Active Bacterial Core Surveillance Team. Schrag SJ, et al. N Engl J Med. 2002 Jul 25;347(4):233-9. doi: 10.1056/NEJMoa020205. N Engl J Med. 2002. PMID: 12140298 Free article.

7

Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Schrag S, et al. MMWR Recomm Rep. 2002 Aug 16;51(RR-11):1-22. MMWR Recomm Rep. 2002. PMID: 12211284 Free article.

8

A human papillomavirus type 16 vaccine.

Schrag SJ, Schuchat A, Schulkin J. Schrag SJ, et al. N Engl J Med. 2003 Apr 3;348(14):1402-5; author reply 1402-5. N Engl J Med. 2003. PMID: 12678020 No abstract available.

9

Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis.

Moore MR, Schrag SJ, Schuchat A. Moore MR, et al. Among authors: schrag sj. Lancet Infect Dis. 2003 Apr;3(4):201-13. doi: 10.1016/s1473-3099(03)00577-2. Lancet Infect Dis. 2003. PMID: 12679263 Review.

10

Vaccination and perinatal infection prevention practices among obstetrician-gynecologists.

Schrag SJ, Fiore AE, Gonik B, Malik T, Reef S, Singleton JA, Schuchat A, Schulkin J. Schrag SJ, et al. Obstet Gynecol. 2003 Apr;101(4):704-10. doi: 10.1016/s0029-7844(03)00010-3. Obstet Gynecol. 2003. PMID: 12681874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters